Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (661-670 of 679) with videos related to

Pageof 68
Sort By:
Journal of the American Heart Association|January 12, 2024
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality RiskMarie de Bakker, Niels T B Scholte, Rohit M Oemrawsingh, et al.
BMJ Open|December 25, 2016
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the NetherlandsRohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, et al.
JACC. Cardiovascular Interventions|March 27, 2024
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary SyndromeJacob J Elscot, Hala Kakar, Paola Scarparo, et al.
European Heart Journal. Acute Cardiovascular Care|April 25, 2023
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohortMuhammed T Gürgöze, K Martijn Akkerhuis, Rohit M Oemrawsingh, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 29, 2025
Women's heart disease research in the netherlands: angina with non-obstructive coronary artery disease and beyondElisa Dal Canto, N Charlotte Onland-Moret, Sanne A E Peters, et al.
American Heart Journal|October 24, 2024
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domainMyrthe P J van Steenwijk, Joost van Rosmalen, Carlos V Elzo Kraemer, et al.
JAMA Cardiology|February 19, 2025
Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function TestingCaïa Crooijmans, Tijn P J Jansen, Joan G Meeder, et al.
European Heart Journal|May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trialPascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
Pageof 68

Showing results (661-670 of 679) with videos related to

Sort By:
Pageof 68
Journal of the American Heart Association|January 12, 2024
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality RiskMarie de Bakker, Niels T B Scholte, Rohit M Oemrawsingh, et al.
BMJ Open|December 25, 2016
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the NetherlandsRohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, et al.
JACC. Cardiovascular Interventions|March 27, 2024
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary SyndromeJacob J Elscot, Hala Kakar, Paola Scarparo, et al.
European Heart Journal. Acute Cardiovascular Care|April 25, 2023
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohortMuhammed T Gürgöze, K Martijn Akkerhuis, Rohit M Oemrawsingh, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 29, 2025
Women's heart disease research in the netherlands: angina with non-obstructive coronary artery disease and beyondElisa Dal Canto, N Charlotte Onland-Moret, Sanne A E Peters, et al.
American Heart Journal|October 24, 2024
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domainMyrthe P J van Steenwijk, Joost van Rosmalen, Carlos V Elzo Kraemer, et al.
JAMA Cardiology|February 19, 2025
Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function TestingCaïa Crooijmans, Tijn P J Jansen, Joan G Meeder, et al.
European Heart Journal|May 11, 2024
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trialPascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, et al.
Pageof 68